WallStSmart
QNCX

Quince Therapeutics, Inc.

NASDAQ: QNCX · HEALTHCARE · BIOTECHNOLOGY

$1.26
-8.18% today

Updated 2026-06-05

Market cap
$17.80M
P/E ratio
P/S ratio
EPS (TTM)
$-9.67
Dividend yield
52W range
$1 – $46
Volume
46.7M

Quince Therapeutics, Inc. (QNCX) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item201720182019202020212022202320242025
Total assets$7.72M$72.88M$124.37M$189.47M$133.23M$103.91M$180.20M$114.48M$93.52M
Cash & equivalents$7.34M$24.87M$51.21M$66.84M$69.72M$44.58M$20.75M$6.21M$5.81M
Current assets$7.54M$72.58M$106.06M$137.86M$111.67M$93.75M$77.44M$44.04M$22.90M
Total liabilities$28.00M$1.46M$8.89M$17.20M$14.64M$3.32M$95.12M$84.33M$129.24M
Current liabilities$1.76M$1.46M$8.89M$17.00M$14.22M$3.07M$9.57M$7.28M$43.23M
Long-term debt$13.43M$14.32M
Shareholder equity$-20.28M$71.42M$115.48M$172.26M$118.59M$100.59M$85.08M$30.15M$-35.71M
Retained earnings$-20.35M$-32.83M$-69.81M$-146.65M$-236.60M$-288.26M$-319.64M$-376.47M$-460.45M
Accounts receivable$1.13M$1.00M$993000.00$882000.00$3.62M
Inventory$2.25M$2.29M
Goodwill$0.00$17.63M$0.00

Frequently asked questions

How much free cash flow does QNCX generate?

QNCX produced $-41.78M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is QNCX's balance sheet healthy?

QNCX holds $5.81M in cash and equivalents against — in long-term debt, on $-35.71M of shareholder equity. That debt is best read against the cash flow the business throws off each year.